Biosimilars LatAm – Brazil 2025
As a platform for advancing access to biosimilars in Brazil, this forum convenes senior executives and key stakeholders from the pharmaceutical and regulatory sectors to examine strategies for consolidating Brazil’s leadership in the global biosimilars market. Through engaging panels, expert presentations, and networking sessions, the event explores the role of international alliances, the contributions of ANVISA and academic institutions, and solutions for overcoming regulatory and market challenges to ensure global distribution.
Key Objectives:
– Analyze how alliances with international entities facilitate entry into new markets.
– Discuss the role of ANVISA and universities in fostering research and developing bioprocess talent.
– Address strategies for navigating regulatory and market challenges to enable global distribution of biosimilars.
Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Plan Your 1-to-1 Meetings with JackLeckerman App
1. JackLeckerman App: Login & Meeting Notifications
Download the JackLeckerman App and sign up.
Check your email for the login details, or use the “Forgot Password” option to retrieve them.
You will receive meeting reminders on your mobile over the 2 days.
These reminders will include meeting requests, meeting confirmations, and messages from other attendees and the coordinator.
2. Attendee list to Plan Your Meetings
Browse the attendee list and select someone for a 10-minute 1-to-1 Meeting request.
Meeting requests close one hour before each Networking session in the program.
3. Managing Meeting Requests, Your Meetings Schedule
Accept or decline meeting requests through the “Meetings” button.
Check your scheduled meetings for the upcoming networking break.
4. Meeting Point Location in the Coffee Break Area
Go to the coffee break area and find the table number to meet your colleague
Speaker Board 2024
Suryanarayana Nagendra
LatAm Cluster Head
Ana Maria Moro
Lab Director
Andre Luiz Jochen
Regulatory Affairs and Quality Director
Marco Antonio Fernandes
Business Development Manager
Carla Juliani
Technical Services Manager Latam
Paulo Fernandes
Consultant - Clinical Development
German Wassermann
Biotechnology Director - R&D
Fatima Ventura
Drug Evaluation Department - Scientific Evaluation Unit
Mariana de Cerqueira
Upstream and Cell Culture Sales Specialist
Alexander Schäfer
Business Development Manager
Juan Amor
Technical Application Specialist (Purification)
Justin Sweeley
Integrated Solutions Sales Manager, North America West
Liana Dalolli
Biopharma Business Unit Director
Cristiano Gonçalves
Director of Innovation and Tech Licensing
Fernando de Rezende Francisco
Executive Manager
Ricardo Campello
Partner
Uilberson Silva
RD&I Director
Marcela Amaral Pontes
Access Manager
Perla Villani Borges
Business Development Manager
Francisco Javier Domingo
Business Unit Director Spain
Anderson Montai
Manager, Specialist in Health Regulation and Surveillance
Flavio Spegiorin Ramos
Partner
Philippe Lauwers
Technology Development Director
Program at a Glance
Aligning Brazilian Compliance with EMA Standards for European Market Access
Explore strategies for aligning Brazilian biosimilars with EMA regulatory standards.
Global Regulatory Collaboration: ANVISA and FDA
Explain the recent confidentiality agreement between ANVISA and the FDA and its impact on regulatory cooperation.
Strategic Alliances for Brazilian Biosimilars’ Global Expansion
Analyze how alliances with foreign entities facilitate entry into new markets.
Digital Transformation in Bioprocessing: AI and Machine Learning
Explore how AI enhances efficiency and competitiveness in biosimilar production.
Biocompatibility and Quality Standards for International Markets
Emphasize the importance of biocompatibility and quality for Brazilian biosimilars in export markets.
Strengthening Talent through ANVISA and Academia
Discuss how ANVISA and universities support research and bioprocess talent development.
Investment and Sustainability in SUS for Biosimilars
Analyze the impact of government investment on the local biosimilar industry and healthcare system.
Overcoming Barriers in Global Market Access for Biosimilars
Discuss strategies to navigate regulatory and market challenges for global distribution of biosimilars.
Full Programme in the PDF Agenda
Download Agenda
Photo Gallery from Previous Events
Testimonials
-
”It was an excellent opportunity to hear what the authorities industry, even sometimes what our competitors or other providers have to say about the topic.”
Alison Bascou, Sr. Regulatory Director at BD, France
-
"I think it's being an interesting event. Wherever there's discussion at top level, wherever there's respect. wherever there's an open forum, science can advance. It's very important to keep patient's well-being in mind and I think this forum allows that."
Jaime Uribe, CEO At PROBIOMED
-
“The strength of the biosimilar industry in our region is very encouraging. It seems to me this event is the propitious forum to share experiences and it is great.”
Tammy Boggiano Ayo, Process Development Director at CIM, Cuba
-
“It showed a broad picture, from a highly technical perspective up to a commercial viewpoint. It is not easy to get that in such a short period of time.”
Santiago Salguero, Executive Director at Pharmaceutical Association of Ecuador
-
“For companies like those I work for, i.e. suppliers to the pharmaceutical industry, this has been a great opportunity to see our clients’ perspective and above all to identify the major trends determining the future of biosimilars.”
Mauricio Roberto Hernández Morales, Key Account and Business Developer Manager at BD Mexico